PORTAIL DOCUMENTAIRE

Article

Tamoxifen and Breast Cancer incidence Among women with inherited mutations in BRCA1 and BRCA2 : National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

Mary-Claire KING ; Joseph COSTANTINO ; Barbara-K DUNN ; Bernard FISHER ; Leslie FORD ; Kathryn HALE ; Ming LEE ; Kelly OWENS ; Jonathan TAIT ; T.O.M. WALSH ; Lawrence WICKERHAM ; S.A.M. WIEAND ; Norman WOLMARK ; Departments and Medicine and Genomic Sciences. University of Washington. Seattle. USA ; National Surgical Adjuvant Breast and Bowel Project. University of Pittsburgh. Pittsburgh. PA. USA |

Dans JAMA - Journal of the american medical association (vol. 286, n° 18, 2001)

[BDSP. Notice produite par INIST-CNRS qRR0xlzI. Diffusion soumise à autorisation]. Context Among cancer-free women aged 35 years or older, tamoxifen reduced the incidence of estrogen receptor (ER) - positive but not ER-negative breast cancer. Th[...]

Plus d'information...

Ajouter à ma sélection